People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Silverback Therapeutics, Inc. | — | Biotechnology | Series C | $139.3M | $3.2B | 2020 |
Thilo L. Schroeder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thilo L. Schroeder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Thompson | 1 | 16 |
| Jonathan Root | 1 | 16 |
| Laura Shawver | 1 | 6 |
| Peter A. Thompson | 1 | 5 |
| Robert Hershberg | 1 | 3 |
| Vickie L. Capps | 1 | 3 |
| Thilo Schroeder | 1 | 2 |
| Saqib A. Islam | 1 | 1 |
| Jonathan L. Root | 1 | 1 |
| Scott L. Platshon | 1 | 1 |
| Robert L. Hershberg | 1 | 1 |
| Saqib L. Islam | 1 | 1 |
| Saqib Islam | 1 | 1 |
| Robert A. Hershberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.